Position in ERAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,872,755
+$8,340,498 QoQ
Shares Held
1,958,120
+15.1% QoQ
Ownership
0.560%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. ERAS ranks #48 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,872,755 | 1,958,120 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $27,532,257 | 1,701,623 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,953,209 | 1,331,508 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,146,852 | 1,443,511 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,791,997 | 1,411,022 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,282,156 | 1,665,809 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,309,942 | 1,717,109 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,198,599 | 1,537,949 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,014,591 | 853,641 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,364,720 | 662,486 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,492,952 | 700,917 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,414,664 | 718,105 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,917,530 | 694,758 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,975,418 | 656,286 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,492,285 | 578,257 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,250,047 | 544,878 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,681,998 | 481,508 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,086,125 | 475,131 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,943,139 | 188,905 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,877,084 | 182,709 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||